Search - tctmd.com

Displaying 621 - 640 of 872

Sort: Relevancy | Date

News Industry News

BOSTON SCIENTIFIC LOTUS™ VALVE SYSTEM MEETS

October 31, 2013

Presentation TCT 2013

Case #1: Off-Label Transcatheter Valve Implantation In Aortic Regurgitation

Presenter: Julia Jorgova

October 30, 2013

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

News Industry News

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

October 30, 2013

Presentation TCT 2013

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

Presenter: Michael Rinaldi

October 29, 2013

Presentation TCT 2013

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Presenter: Andreas R?ck

October 29, 2013

Presentation TCT 2013

Case Presentations: The Issue: Introducing Two Cases of Mitral Regurgitation (One Degenerative MR, One Functional MR) Which Might Invoke Different Approaches

Presenter: Francesco Maisano

October 29, 2013

Presentation

The Implications of Heart Failure and Mitral Regurgitation: What Is the Magnitude of the Economic Impact?

Presenter: Michael Rinaldi

October 29, 2013

Presentation

Techniques for Surgical Treatment of Mitral Regurgitation

Presenter: Michael Argenziano

October 29, 2013

Presentation TCT 2013

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

Presenter: Edith Lubos

October 29, 2013

Presentation TCT 2013

TCT-89. Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical...

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Presenter: Baris Bugan

October 29, 2013

Presentation TCT 2013

TCT-105. Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve...

Presenter: Leo Marcoff

October 29, 2013

Presentation TCT 2013

Echocardiographic Results in the CoreValve US Extreme Risk Study: Hemodynamics and Aortic Regurgitation

Presenter: Jae Oh

October 29, 2013

Presentation TCT 2013

Case Presentation #2: Acute Anterior MI Presenting with Cardiogenic Shock and Complicated by Severe Mitral Regurgitation

Presenter: Anita Asgar

October 29, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

Presentation TCT 2013

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Presenter: Jeffrey Borer

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

MitraClip: Utility in Functional Mitral Regurgitation

Presenter: Laura Mauri

October 28, 2013

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Advertisement

BOSTON SCIENTIFIC LOTUS™ VALVE SYSTEM MEETS

Case #1: Off-Label Transcatheter Valve Implantation In Aortic Regurgitation

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Case Presentations: The Issue: Introducing Two Cases of Mitral Regurgitation (One Degenerative MR, One Functional MR) Which Might Invoke Different Approaches

The Implications of Heart Failure and Mitral Regurgitation: What Is the Magnitude of the Economic Impact?

Techniques for Surgical Treatment of Mitral Regurgitation

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

TCT-89. Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical...

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

TCT-105. Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve...

Echocardiographic Results in the CoreValve US Extreme Risk Study: Hemodynamics and Aortic Regurgitation

Case Presentation #2: Acute Anterior MI Presenting with Cardiogenic Shock and Complicated by Severe Mitral Regurgitation

Opportunities Exist to Improve Outcomes in Transapical TAVR

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

MitraClip: Utility in Functional Mitral Regurgitation

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content